Published in Cochrane Database Syst Rev on January 01, 2004
Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams | NCT00277030
Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ (2005) 4.22
What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics. Eur J Pediatr (2007) 0.90
Resuscitation intensity at birth is associated with changes in brain metabolic development in preterm neonates. Neuroradiology (2013) 0.76
Analysis and comparison of the effects of N-BiPAP and Bubble-CPAP in treatment of preterm newborns with the weight of below 1500 grams affiliated with respiratory distress syndrome: A randomised clinical trial. Adv Biomed Res (2016) 0.75
Management of Respiratory Distress in the Newborn. Med J Armed Forces India (2011) 0.75
More and earlier surfactant for preterm infants. Arch Dis Child Fetal Neonatal Ed (2006) 0.75
Consensus approach to nasal high-flow therapy in neonates. J Perinatol (2017) 0.75
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics (2001) 2.87
A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med (1989) 1.99
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (2007) 1.85
Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics (2001) 1.75
Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial. J Perinatol (2012) 1.73
Cranial ultrasound and MRI at term age in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed (2009) 1.61
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) 1.52
Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed (2001) 1.46
Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics (1990) 1.40
Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol (1997) 1.38
A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr (1990) 1.26
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics (1987) 1.18
The prognostic value of early aEEG in asphyxiated infants undergoing systemic hypothermia treatment. Acta Paediatr (2009) 1.13
Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res (1996) 1.12
Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res (2001) 1.09
Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood (1993) 1.06
Renal function in very low birth weight infants: normal maturity reached during early childhood. J Pediatr (1992) 1.03
Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol (2007) 1.01
Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res (1998) 1.00
Predictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disability. Am J Obstet Gynecol (1999) 1.00
Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed (1995) 0.96
Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr (1993) 0.95
Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2001) 0.93
Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. Pediatrics (1991) 0.93
Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev (2007) 0.92
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev (2002) 0.92
Outdoor environmental assessment of attention promoting settings for preschool children. Health Place (2009) 0.92
Acellular pertussis vaccine in adults: adverse reactions and immune response. Eur J Clin Microbiol (1987) 0.91
Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol (1989) 0.91
Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6. Dev Biol Stand (1986) 0.89
Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr (2002) 0.88
Investigations for neonatal seizures. Semin Fetal Neonatal Med (2013) 0.87
Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev (2004) 0.86
Current surfactant use in premature infants. Clin Perinatol (2001) 0.85
[Report on the adverse effects of an English whooping cough vaccine for infants based on a clinical trial]. Lakartidningen (1984) 0.84
Clinical trials of natural surfactant extract in respiratory distress syndrome. Clin Perinatol (1993) 0.84
Long-chain polyunsaturated fatty acids in human milk and brain growth during early infancy. Acta Paediatr (2000) 0.83
Concentrations of magnesium and ionized calcium in umbilical cord blood in distressed term newborn infants with hypoxic-ischemic encephalopathy. Acta Paediatr (1996) 0.82
Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med (2014) 0.82
Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy. J Perinatol (2010) 0.82
Cerebrospinal fluid of newborn infants contains a deglycosylated form of the intermediate filament nestin. Pediatr Res (1996) 0.81
Investigating the European perspective of neonatal point-of-care echocardiography in the neonatal intensive care unit--a pilot study. Eur J Pediatr (2013) 0.80
Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Paediatr (1999) 0.79
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev (2007) 0.79
The quality of the outdoor environment influences childrens health -- a cross-sectional study of preschools. Acta Paediatr (2012) 0.79
Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev (2001) 0.79
Approach to seizures in the neonatal period: a European perspective. Acta Paediatr (2010) 0.79
Autism: screening toddlers with CHAT in a child health care programme did not improve early identification. Acta Paediatr (2010) 0.79
Vaccination of children--a systematic review. Acta Paediatr Suppl (2010) 0.79
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev (2007) 0.78
Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines. Vaccine (1997) 0.77
Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. Aliment Pharmacol Ther (2004) 0.77
A ten year follow-up after immunization with a two component acellular pertussis vaccine. Pediatr Infect Dis J (1999) 0.76
Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2008) 0.76
The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis. Thromb Haemost (1995) 0.76
Timing of surfactant treatment. Arch Dis Child Fetal Neonatal Ed (1998) 0.75
Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev (2003) 0.75
Introduction to neonatal systematic reviews. Pediatrics (1997) 0.75
Absorption of erythromycin from pediatric suspension in infants and children. Scand J Infect Dis (1981) 0.75
Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2000) 0.75
[A new vaccination campaign for better protection against whooping cough of infants]. Lakartidningen (1999) 0.75
Episodic abnormalities in transcutaneous oxygen (TcPO2) recorded during neonatal intensive care. J Perinatol (1987) 0.75
[Children in a day care center that concentrates on outdoor activities are less frequently sick]. Lakartidningen (1998) 0.75
Effects of hyperglycemia on gasping and autoresuscitation in newborn rats. Biol Neonate (1997) 0.75
Exogenous surfactant therapy in newborn infants. Ann Acad Med Singapore (2003) 0.75
Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing? Eur J Pediatr (1994) 0.75